Consort Medical plc (LON:CSRT) Plans Dividend Increase – GBX 13.80 Per Share

Consort Medical plc (LON:CSRT) declared a dividend on Thursday, June 13th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, September 19th will be paid a dividend of GBX 13.80 ($0.18) per share on Friday, October 25th. This represents a dividend yield of 1.53%. The ex-dividend date of this dividend is Thursday, September 19th. This is an increase from Consort Medical’s previous dividend of $7.60. The official announcement can be viewed at this link.

Shares of CSRT opened at GBX 898 ($11.73) on Friday. The company has a quick ratio of 1.32, a current ratio of 1.92 and a debt-to-equity ratio of 48.36. The stock has a market capitalization of $442.01 million and a PE ratio of 26.33. Consort Medical has a 52-week low of GBX 700 ($9.15) and a 52-week high of GBX 1,294 ($16.91).

A number of equities analysts have recently issued reports on the stock. Shore Capital reiterated a “buy” rating on shares of Consort Medical in a report on Thursday. Numis Securities downgraded shares of Consort Medical to a “hold” rating in a report on Thursday, June 6th. Finally, Royal Bank of Canada cut their price target on shares of Consort Medical from GBX 1,320 ($17.25) to GBX 1,130 ($14.77) and set an “outperform” rating for the company in a report on Thursday.

TRADEMARK VIOLATION NOTICE: This news story was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://sportsperspectives.com/2019/06/14/consort-medical-plc-loncsrt-plans-dividend-increase-gbx-13-80-per-share.html.

About Consort Medical

Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.

See Also: What is the balance sheet?

Dividend History for Consort Medical (LON:CSRT)

Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with MarketBeat.com's FREE daily email newsletter.